Amplia Therapeutics Reports Promising Preclinical Narmafotinib Data in Pancreatic Cancer
MELBOURNE, Australia, July 30, 2026 Amplia Therapeutics announced the online publication of comprehensive preclinical findings evaluating narmafotinib in pancreatic...
